4th Quarter - Report
OLD NORTH STRATEGIES, LLC for EXELA PHARMA SCIENCES, LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$78,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 10, 2024 | $78,000 | Replaced |
| 4th Quarter - Amendment | Jan 10, 2024 | $138,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
supply chain & FDA issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH WAYNE KING | Deputy Chief of Staff Congressman Mark Meadows Senior Advisor Dr. Greg Murphy |
Health Issues HCR
supply chain & FDA issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH WAYNE KING | — |
Medical/Disease Research/Clinical Labs MED
supply chain & FDA issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH WAYNE KING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.